2019 Exhibitors & Booth Assignments
Sunday, June 23, 6:00 pm–8:00 pm—Welcome Reception and Poster Session 1 in Exhibit Hall
Monday, June 24, 6:00 pm–8: 00 pm—Poster Session 2 in Exhibit Hall
Exhibit hours are subject to change.
As of November 7, 2018
|505 King Avenue||Website: www.battelle.org|
|Columbus, OH 43201|
Battelle, the world's largest, independent R&D organization, conducts Developmental and Reproductive (DART) studies for a broad range of chemicals and pharmaceuticals. We provide studies used for required preclinical studies for US FDA approval of new drug and biologic therapies, product registration for agrichemicals, and evaluation al and reproductive effects of industrial chemicals and environmental toxins.
|Charles River||Tel: 877.CRIVER.1|
|251 Ballardvale Street||Website: www.criver.com|
|Wilmington, MA 01887|
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions accelerate and improve their research and drug development efforts to expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more visit www.criver.com.
|445 Boulevard Armand Frappier||Website: www.citoxlab.com|
|Laval, QC H7V4B3|
With ten facilities, Citoxlab Group offers a comprehensive range of preclinical services to meet the needs of pharmaceutical, biotechnology, medical device, chemical and agrochemical companies worldwide. Citoxlab carries out studies in general and reproductive toxicology, carcinogenicity, immunology, pharmacology, pharmacokinetics, and bioanalysis/biomarkers.
1800 Diagonal Road, Suite 500
Alexandria, VA 22314
Exponent’s veteran toxicologists and epidemiologists are drawn from the chemical and pharmaceutical industries, academia, and government. They have international regulatory experience in designing and interpreting developmental and reproductive toxicity (DART) and developmental neurotoxicology studies; assessing potential endocrine disruption; performing quantitative risk assessments and cancer risk assessments related to children. Our experts are also ready to assist you in complying with the new FDA Pregnancy and Lactation Labeling Rule.